Literature DB >> 16864569

Physiological left ventricular hypertrophy or hypertrophic cardiomyopathy in an elite adolescent athlete: role of detraining in resolving the clinical dilemma.

S Basavarajaiah1, M Wilson, S Junagde, G Jackson, G Whyte, S Sharma, W O Roberts.   

Abstract

The differentiation of physiological left ventricular hypertrophy (LVH) from hypertrophic cardiomyopathy (HCM) can prove challenging for even the most experienced cardiologists. The case is presented of a 17 year old elite swimmer who had electrocardiographic and echocardiographic features that were highly suggestive of HCM. However, indices of diastolic function were normal and cardiopulmonary exercise testing revealed high peak oxygen consumption in keeping with physiological LVH. To resolve the diagnostic dilemma, the patient underwent detraining for eight weeks, after which, there was complete resolution of the changes seen on electrocardiogram and echocardiogram, indicating physiological LVH rather than HCM.

Entities:  

Mesh:

Year:  2006        PMID: 16864569      PMCID: PMC2579475          DOI: 10.1136/bjsm.2005.024596

Source DB:  PubMed          Journal:  Br J Sports Med        ISSN: 0306-3674            Impact factor:   13.800


  10 in total

Review 1.  Sudden death from cardiovascular disease in young athletes: fact or fiction?

Authors:  S Sharma; G Whyte; W J McKenna
Journal:  Br J Sports Med       Date:  1997-12       Impact factor: 13.800

2.  Rapid changes in left ventricular dimensions and mass in response to physical conditioning and deconditioning.

Authors:  A A Ehsani; J M Hagberg; R C Hickson
Journal:  Am J Cardiol       Date:  1978-07       Impact factor: 2.778

3.  Utility of metabolic exercise testing in distinguishing hypertrophic cardiomyopathy from physiologic left ventricular hypertrophy in athletes.

Authors:  S Sharma; P M Elliott; G Whyte; N Mahon; M S Virdee; B Mist; W J McKenna
Journal:  J Am Coll Cardiol       Date:  2000-09       Impact factor: 24.094

4.  Utility of cardiopulmonary exercise in the assessment of clinical determinants of functional capacity in hypertrophic cardiomyopathy.

Authors:  S Sharma; P Elliott; G Whyte; S Jones; N Mahon; B Whipp; W J McKenna
Journal:  Am J Cardiol       Date:  2000-07-15       Impact factor: 2.778

5.  Electrocardiographic changes in 1000 highly trained junior elite athletes.

Authors:  S Sharma; G Whyte; P Elliott; M Padula; R Kaushal; N Mahon; W J McKenna
Journal:  Br J Sports Med       Date:  1999-10       Impact factor: 13.800

6.  Reduction in left ventricular wall thickness after deconditioning in highly trained Olympic athletes.

Authors:  B J Maron; A Pelliccia; A Spataro; M Granata
Journal:  Br Heart J       Date:  1993-02

Review 7.  Causes of sudden death in competitive athletes.

Authors:  B J Maron; S E Epstein; W C Roberts
Journal:  J Am Coll Cardiol       Date:  1986-01       Impact factor: 24.094

8.  The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes.

Authors:  A Pelliccia; B J Maron; A Spataro; M A Proschan; P Spirito
Journal:  N Engl J Med       Date:  1991-01-31       Impact factor: 91.245

9.  Physiologic limits of left ventricular hypertrophy in elite junior athletes: relevance to differential diagnosis of athlete's heart and hypertrophic cardiomyopathy.

Authors:  Sanjay Sharma; Barry J Maron; Greg Whyte; Sami Firoozi; Perry M Elliott; William J McKenna
Journal:  J Am Coll Cardiol       Date:  2002-10-16       Impact factor: 24.094

Review 10.  Cardiac disease in young trained athletes. Insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy.

Authors:  B J Maron; A Pelliccia; P Spirito
Journal:  Circulation       Date:  1995-03-01       Impact factor: 29.690

  10 in total
  9 in total

1.  Electrocardiographic changes in an athlete before and after detraining.

Authors:  Saqib Ghani; Sanjay Sharma
Journal:  BMJ Case Rep       Date:  2012-05-08

Review 2.  Hypertrophic Cardiomyopathy in Athletes.

Authors:  Aneil Malhotra; Sanjay Sharma
Journal:  Eur Cardiol       Date:  2017-12

Review 3.  Noninvasive imaging modalities and sudden cardiac arrest in the young: can they help distinguish subjects with a potentially life-threatening abnormality from normals?

Authors:  Beth Feller Printz
Journal:  Pediatr Cardiol       Date:  2012-02-14       Impact factor: 1.655

4.  An autopsy case report of fulminant myocarditis: Following mRNA COVID-19 vaccination.

Authors:  Naoki Hoshino; Masanobu Yanase; Taisuke Ichiyasu; Kazuhiko Kuwahara; Hideki Kawai; Takashi Muramatsu; Hideki Ishii; Tetsuya Tsukamoto; Shin-Ichiro Morimoto; Hideo Izawa
Journal:  J Cardiol Cases       Date:  2022-07-04

Review 5.  Athlete's heart or hypertrophic cardiomyopathy?

Authors:  Jörg Lauschke; Bernhard Maisch
Journal:  Clin Res Cardiol       Date:  2008-10-13       Impact factor: 5.460

6.  Detraining-related changes in left ventricular wall thickness and longitudinal strain in a young athlete likely to have hypertrophic cardiomyopathy.

Authors:  Cesare de Gregorio; Giampiero Speranza; Alberto Magliarditi; Pietro Pugliatti; Giuseppe Andò; Sebastiano Coglitore
Journal:  J Sports Sci Med       Date:  2012-09-01       Impact factor: 2.988

Review 7.  Impact of ethnicity on cardiac adaptation to exercise.

Authors:  Nabeel Sheikh; Sanjay Sharma
Journal:  Nat Rev Cardiol       Date:  2014-02-25       Impact factor: 32.419

8.  Prevalence of electrocardiographic abnormalities in West-Asian and African male athletes.

Authors:  M G Wilson; J C Chatard; F Carre; B Hamilton; G P Whyte; S Sharma; H Chalabi
Journal:  Br J Sports Med       Date:  2011-05-19       Impact factor: 13.800

Review 9.  Risk stratification of sudden cardiac death in hypertension.

Authors:  Larisa G Tereshchenko; Elsayed Z Soliman; Barry R Davis; Suzanne Oparil
Journal:  J Electrocardiol       Date:  2017-08-14       Impact factor: 1.438

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.